{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T02:03:25Z","timestamp":1700705005020},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1053\/bega.1999.0076","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:54:50Z","timestamp":1032443690000},"page":"277-291","source":"Crossref","is-referenced-by-count":5,"title":["Complex management issues: management of HCV in the atypical patient"],"prefix":"10.1053","volume":"14","author":[{"given":"Stephanos J","family":"Hadziyannis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Vassilopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/bega.1999.0076_RF1","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0168-8278(99)80154-8","volume":"30","year":"1999","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.1999.0076_RF2","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1056\/NEJM198911303212203","article-title":"Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group","volume":"321","author":"Davis","year":"1989","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0076_RF3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.510240405","article-title":"Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration","volume":"24","author":"Poynard","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/bega.1999.0076_RF4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM199811193392102","article-title":"Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group","volume":"339","author":"Davis","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0076_RF5","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199811193392101","article-title":"Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group","volume":"339","author":"McHutchison","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0076_RF6","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/S0140-6736(98)07124-4","article-title":"Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)","volume":"352","author":"Poynard","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0076_RF7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.1996.v110.pm8613001","article-title":"Outbreak of acute hepatitis C following the use of anti-hepatitis C virus\u2014screened intravenous immunoglobulin therapy","volume":"110","author":"Healey","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2249.1997.508-ce1412.x","article-title":"Clinical outcome of hypogammaglobulinaemic patients following outbreak of acute hepatitis C: 2 year follow up","volume":"110","author":"Christie","year":"1997","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1053\/bega.1999.0076_RF9","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJM199412153312402","article-title":"Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin","volume":"331","author":"Bj\u00f8ro","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0076_RF10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(87)90178-4","article-title":"Alpha-interferon therapy for non-A, non-B hepatitis transmitted by gammaglobulin replacement therapy","volume":"i","author":"Thomson","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/bega.1999.0076_RF11","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1182\/blood.V90.3.1309","article-title":"Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status","volume":"90","author":"Rossi","year":"1997","journal-title":"Blood"},{"key":"10.1053\/bega.1999.0076_RF12","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0168-8278(97)80133-X","article-title":"HCV and hypogammaglobulinemia","volume":"26","author":"Sierra","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.1999.0076_RF13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/00365549850161575","article-title":"Liver transplantation for endstage hepatitis C cirrhosis in a patient with primary hypogammaglobulinaemia","volume":"30","author":"Bj\u00f8ro","year":"1998","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"10.1053\/bega.1999.0076_RF14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/0168-8278(92)90036-O","article-title":"Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation","volume":"15","author":"Pol","year":"1992","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.1999.0076_RF15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00007890-199302000-00008","article-title":"Hepatitis C\u2014its prevalence in end-stage renal failure patients and clinical course after kidney transplantation","volume":"55","author":"Stempel","year":"1993","journal-title":"Transplantation"},{"key":"10.1053\/bega.1999.0076_RF16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ki.1994.29","article-title":"The impact of hepataitis C virus infection on renal allograft recipients","volume":"45","author":"Roth","year":"1994","journal-title":"Kidney International"},{"key":"10.1053\/bega.1999.0076_RF17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/ndt\/11.supp4.48","article-title":"HCV liver disease in renal transplantation: a clinical and histological study","volume":"11","author":"Haem","year":"1996","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1053\/bega.1999.0076_RF18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/00007890-199611270-00007","article-title":"The long-term course of hepatitis C after kidney transplantation","volume":"62","author":"Kliem","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/bega.1999.0076_RF19","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1097\/00007890-199603270-00007","article-title":"A prospective study of hepatitis C virus infection in renal allograft recipients","volume":"61","author":"Roth","year":"1996","journal-title":"Transplantation"},{"key":"10.1053\/bega.1999.0076_RF20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1572-0241.1999.00788.x","article-title":"Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients","volume":"94","author":"Glicklich","year":"1999","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF21","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00007890-199808270-00010","article-title":"Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years","volume":"66","author":"Hanafusa","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.1999.0076_RF22","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00007890-199803150-00011","article-title":"Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients","volume":"65","author":"Legendre","year":"1998","journal-title":"Transplantation"},{"key":"10.1053\/bega.1999.0076_RF23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.510290123","article-title":"Impact of hepatitis B and C virus on kidney transplantation outcome","volume":"29","author":"Mathurin","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.1999.0076_RF24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ndt\/10.supp6.93","article-title":"Preliminary results of treatment of chronic hepatitis C with recombinant interferon alpha in renal transplant patients","volume":"10","author":"Rostaing","year":"1995","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1053\/bega.1999.0076_RF25","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000169133","article-title":"Kinetics of HCV viremia in kidney transplant recipients during and after alpha-interferon therapy","volume":"17","author":"Izopet","year":"1997","journal-title":"American Journal of Nephrology"},{"key":"10.1053\/bega.1999.0076_RF26","first-page":"S135","article-title":"Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients","volume":"11","author":"Durlik","year":"1998","journal-title":"Transplant International"},{"key":"10.1053\/bega.1999.0076_RF27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/00365599609182328","article-title":"Treatment of chronic hepatitis B and C with alpha interferon in a renal transplant patient","volume":"30","author":"Rostaing","year":"1996","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1053\/bega.1999.0076_RF28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00007890-199409150-00018","article-title":"Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study","volume":"58","author":"Therret","year":"1994","journal-title":"Transplantation"},{"key":"10.1053\/bega.1999.0076_RF29","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1182\/blood.V93.4.1127","article-title":"Hepatitis viruses and hematopoietic cell transplantation: a guide to patient and donor management","volume":"93","author":"Strasser","year":"1999","journal-title":"Blood"},{"key":"10.1053\/bega.1999.0076_RF30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.510290609","article-title":"Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up","volume":"29","author":"Strasser","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/bega.1999.0076_RF31","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1182\/blood.V93.10.3259.410k13_3259_3266","article-title":"Cirrhosis of the liver in long-term marrow transplant survivors","volume":"93","author":"Strasser","year":"1999","journal-title":"Blood"},{"key":"10.1053\/bega.1999.0076_RF32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/sj.bmt.1700968","article-title":"Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia","volume":"20","author":"Giardini","year":"1997","journal-title":"Bone Marrow Transplantation"},{"key":"10.1053\/bega.1999.0076_RF33","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0889-857X(05)70096-X","article-title":"Selected drug complications and treatment conflicts in the presence of coexistent diseases","volume":"25","author":"Vassilopoulos","year":"1999","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"10.1053\/bega.1999.0076_RF34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0016-5085(94)90077-9","article-title":"Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C","volume":"107","author":"Fong","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF35","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/hep.1840190203","article-title":"Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment","volume":"19","author":"Magrin","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/bega.1999.0076_RF36","first-page":"300","article-title":"Steroid therapy of chronic hepatitis: characteristics associated with response in anti-hepatitis C virus-positive and -negative patients","volume":"91","author":"Thiele","year":"1996","journal-title":"American Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF37","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1182\/blood.V84.10.3336.3336","article-title":"Natural interferon-alpha versus its combination of 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study","volume":"84","author":"Dammacco","year":"1994","journal-title":"Blood"},{"key":"10.1053\/bega.1999.0076_RF38","first-page":"97","article-title":"Hepatitis C in renal dialysis and transplant patients","volume":"2","author":"Rosen","year":"1996","journal-title":"Viral Hepatitis Reviews"},{"key":"10.1053\/bega.1999.0076_RF39","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0016-5085(95)90088-8","article-title":"The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients","volume":"108","author":"Pol","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF40","first-page":"256","article-title":"Prevalence and clinical expression of HCV-genotypes in haemodialysis-patients of two geographically remote countries: Belgium and Saudi-Arabia","volume":"47","author":"Bosmans","year":"1997","journal-title":"Clinical Nephrology"},{"key":"10.1053\/bega.1999.0076_RF41","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/oxfordjournals.ndt.a027359","article-title":"Hepatitis C virus genotypes in chronic dialysis patients","volume":"11","author":"Fabrizi","year":"1996","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1053\/bega.1999.0076_RF42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1440-1746.1998.01551.x","article-title":"Cryoglobulinaemia among maintenance haemodialysis patients and its relation to hepatitis C infection","volume":"13","author":"Okuda","year":"1998","journal-title":"Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.1999.0076_RF43","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1086\/517339","article-title":"High rate of hepatitis C virus clearance in hemodialysis patients after interferon-alpha therapy","volume":"176","author":"Izopet","year":"1997","journal-title":"Journal of Infectious Diseases"},{"key":"10.1053\/bega.1999.0076_RF44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0272-6386(99)70108-3","article-title":"Interferon-alpha in chronic hepatitis C infection in dialysis patients","volume":"34","author":"Huraib","year":"1999","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1053\/bega.1999.0076_RF45","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/ki.1995.198","article-title":"Efficacy and tolerance of alpha-2b interferon therapy on HCV infection of hemodialyzed patients","volume":"47","author":"Pol","year":"1995","journal-title":"Kidney International"},{"key":"10.1053\/bega.1999.0076_RF46","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1681\/ASN.V9122344","article-title":"Pharmacokinetics of alpha IFN-2b in chronic hepatitis C virus patients undergoing chronic hemodialysis or with normal renal function: clinical implications","volume":"9","author":"Rostaing","year":"1998","journal-title":"Journal of American Society of Nephrology"},{"key":"10.1053\/bega.1999.0076_RF47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000045125","article-title":"Interferon therapy for chronic hepatitis C in hemodialysis patients: increased serum levels of interferon","volume":"80","author":"Uchihara","year":"1998","journal-title":"Nephron"},{"key":"10.1053\/bega.1999.0076_RF48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF00945029","article-title":"The etiology and pathophysiology of mixed cryoglobulinemia secondary to hepatitis C virus infection","volume":"19","author":"Agnello","year":"1997","journal-title":"Springer Seminars in Immunopathology"},{"key":"10.1053\/bega.1999.0076_RF49","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/archderm.1995.01690220025005","article-title":"Cutaneous vasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus-induced mixed cryoglobulinemia","volume":"131","author":"Karlsberg","year":"1995","journal-title":"Archives of Dermatology"},{"key":"10.1053\/bega.1999.0076_RF50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2249.1996.d01-639.x","article-title":"Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection","volume":"104","author":"Wong","year":"1996","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1053\/bega.1999.0076_RF51","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00004836-199712000-00013","article-title":"Prevalence of cryoglobulinemia in chronic hepatitis C virus infection and response to treatment with interferon-alpha","volume":"25","author":"Akriviadis","year":"1997","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0049-0172(98)80043-7","article-title":"Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients","volume":"28","author":"Buskila","year":"1998","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"10.1053\/bega.1999.0076_RF53","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0168-8278(98)80054-8","article-title":"A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany","volume":"29","author":"Weiner","year":"1998","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.1999.0076_RF54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gut.45.1.122","article-title":"Response to interferon \u03b1 treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus","volume":"45","author":"Cresta","year":"1999","journal-title":"Gut"},{"key":"10.1053\/bega.1999.0076_RF55","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1097\/00042737-199711000-00008","article-title":"Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia","volume":"9","author":"Adinolfi","year":"1997","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.1999.0076_RF56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8278(97)80281-4","article-title":"Interferon-alpha treatment of hepatitis C virus-associated mixed cryoglobulinemia","volume":"27","author":"Polzien","year":"1997","journal-title":"Journal of Hepatology"},{"key":"10.1053\/bega.1999.0076_RF57","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood.V92.8.2983","article-title":"Interferon and ribavirin combination therapy in patients with chronic hepatitis C and mixed cryoglobulinemia","volume":"92","author":"Donada","year":"1998","journal-title":"Blood"},{"key":"10.1053\/bega.1999.0076_RF58","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/bega.1999.0076_RF59","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1182\/blood.V92.2.516","article-title":"High prevalence of serum cryoglobulins in multitransfused hemophilic patients with chronic hepatitis C","volume":"92","author":"Santagostino","year":"1998","journal-title":"Blood"},{"key":"10.1053\/bega.1999.0076_RF60","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/0002-9343(87)90904-1","article-title":"Treatment of idiopathic mixed cryoglobulinemia with alpha interferon","volume":"83","author":"Bonomo","year":"1987","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.1999.0076_RF61","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/infdis\/162.2.569","article-title":"Hepatitis C virus in patients with cryoglobulinemia type II","volume":"162","author":"Pascual","year":"1990","journal-title":"Journal of Infectious Diseases"},{"key":"10.1053\/bega.1999.0076_RF62","first-page":"111","article-title":"Hepatitis C virus infection and cryoglobulinemia","volume":"2","author":"Lunel","year":"1996","journal-title":"Viral Hepatitis Reviews"},{"key":"10.1053\/bega.1999.0076_RF63","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V81.5.1132.1132","article-title":"Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial","volume":"81","author":"Ferri","year":"1993","journal-title":"Blood"},{"key":"10.1053\/bega.1999.0076_RF64","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/0016-5085(94)90022-1","article-title":"Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage","volume":"106","author":"Lunel","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF65","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1002\/(SICI)1097-0142(19960615)77:12<2604::AID-CNCR26>3.0.CO;2-V","article-title":"Regression of monoclonal B-cell expansion in patients affected by mixed cryoglobulinemia responsive to alpha-interferon therapy","volume":"77","author":"Mazzaro","year":"1996","journal-title":"Cancer"},{"key":"10.1053\/bega.1999.0076_RF66","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood.V90.10.3865","article-title":"Predictors of long-term response to high-dose interferon therapy in type II cryoglobulinemia associated with hepatitis C virus infection","volume":"90","author":"Casato","year":"1997","journal-title":"Blood"},{"key":"10.1053\/bega.1999.0076_RF67","first-page":"343","article-title":"Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy","volume":"29","author":"Mazzaro","year":"1997","journal-title":"Italian Journal of Gastroenterology and Hepatology"},{"key":"10.1053\/bega.1999.0076_RF68","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-125-9-199611010-00030","article-title":"Mixed cryoglobulinemia and membranoproliferative glomerulonephritis associated with hepatitis C virus infection","volume":"125","author":"Lopes","year":"1996","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.1999.0076_RF69","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/lt.500020403","article-title":"Beneficial effect of ribavirin on hepatitis C-associated cryoglobulinemia after liver transplantation","volume":"2","author":"Safadi","year":"1996","journal-title":"Liver Transplantation & Surgery"},{"key":"10.1053\/bega.1999.0076_RF70","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1086\/516989","article-title":"Ribavirin therapy for cryoglobulinemia and thrombocytopenia associated with hepatitis C virus infection","volume":"25","author":"Blanche","year":"1997","journal-title":"Clinical Infectious Diseases"},{"key":"10.1053\/bega.1999.0076_RF71","first-page":"1115","article-title":"Ribavirin in hepatitis C related cryoglobulinemia","volume":"25","author":"Durand","year":"1998","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/bega.1999.0076_RF72","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1046\/j.1523-1755.1998.00113.x","article-title":"Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients","volume":"54","author":"Pham","year":"1998","journal-title":"Kidney International"},{"key":"10.1053\/bega.1999.0076_RF73","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0002-9343(99)00014-5","article-title":"Renal manifestations of hepatitis C infection","volume":"106","author":"Daghestani","year":"1999","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.1999.0076_RF74","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2169\/internalmedicine.37.836","article-title":"Glomerulonephritis in autopsy cases with hepatitis C virus infection","volume":"37","author":"Arase","year":"1998","journal-title":"Internal Medicine"},{"key":"10.1053\/bega.1999.0076_RF75","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1046\/j.1523-1755.1998.00028.x","article-title":"Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis","volume":"54","author":"D'Amico","year":"1998","journal-title":"Kidney International"},{"key":"10.1053\/bega.1999.0076_RF76","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1681\/ASN.V9122244","article-title":"Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"9","author":"Markowitz","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1053\/bega.1999.0076_RF77","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/ki.1995.78","article-title":"Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis","volume":"47","author":"Tarantino","year":"1995","journal-title":"Kidney International"},{"key":"10.1053\/bega.1999.0076_RF78","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0002-9343(80)90390-3","article-title":"Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients","volume":"69","author":"Gorevic","year":"1980","journal-title":"American Journal of Medicine"},{"key":"10.1053\/bega.1999.0076_RF79","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/ki.1994.471","article-title":"Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy","volume":"46","author":"Johnson","year":"1994","journal-title":"Kidney International"},{"key":"10.1053\/bega.1999.0076_RF80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0272-6386(97)90572-2","article-title":"Response to high-dose interferon-\u03b1 after failure of standard therapy in MPGN associated with hepatitis C virus infection","volume":"30","author":"Sarac","year":"1997","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1053\/bega.1999.0076_RF81","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1093\/ndt\/14.6.1558","article-title":"Successful treatment of HCV-associated cryoglobulinaemic glomerulonephritis with a combination of interferon-alpha and ribavirin","volume":"14","author":"Misiani","year":"1999","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1053\/bega.1999.0076_RF82","first-page":"253","article-title":"Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients","volume":"9","author":"Quint","year":"1991","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1053\/bega.1999.0076_RF83","doi-asserted-by":"crossref","first-page":"605","DOI":"10.7326\/0003-4819-116-7-605_2","article-title":"Polyarteritis nodosa and hepatitis C virus infection","volume":"116","author":"Cacoub","year":"1992","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.1999.0076_RF84","first-page":"304","article-title":"Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa","volume":"20","author":"Carson","year":"1993","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/bega.1999.0076_RF85","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/00004836-199804000-00013","article-title":"Colonic ulcers in a patient with hepatitis C virus-associated polyarteritis nodosa","volume":"26","author":"Elias","year":"1998","journal-title":"Journal of Clinical Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00002281-199801000-00008","article-title":"Infections and systemic vasculitis","volume":"10","author":"Mandell","year":"1998","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1053\/bega.1999.0076_RF87","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF02358379","article-title":"Deterioration of mixed cryoglobulinemia during treatment with interferon-alpha-2a","volume":"29","author":"Bojic","year":"1994","journal-title":"Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF88","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1995.03530020044018","article-title":"Dramatic worsening of hepatitis C virus-related cryoglobulinemia subsequent to treatment with interferon alfa","volume":"274","author":"Harle","year":"1995","journal-title":"Journal of the American Medical Association"},{"key":"10.1053\/bega.1999.0076_RF89","first-page":"2488","article-title":"Peripheral neuropathy during interferon-alpha therapy in patients with cryoglobulinemia and hepatitis virus infection","volume":"24","author":"Zuber","year":"1997","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/bega.1999.0076_RF90","first-page":"506","article-title":"Interferon toxicity in hepatitis C virus-associated type II cryoglobulinemia","volume":"16","author":"Di Lullo","year":"1998","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1053\/bega.1999.0076_RF91","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0163-4453(98)80022-4","article-title":"Acute exacerbation of vasculitis during interferon-alpha therapy for hepatitis C-associated cryoglobulinaemia","volume":"36","author":"Gordon","year":"1998","journal-title":"Journal of Infection"},{"key":"10.1053\/bega.1999.0076_RF92","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/1529-0131(199905)42:5<1051::AID-ANR26>3.0.CO;2-Q","article-title":"Interferon-\u03b1 may exacerbate cryoglobulinemia-related ischemic manifestations. An adverse effect potentially related to its anti-angiogenic activity","volume":"42","author":"Cid","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1053\/bega.1999.0076_RF93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7326\/0003-4819-122-3-199502010-00002","article-title":"Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes","volume":"122","author":"Pawlotsky","year":"1995","journal-title":"Annals of Internal Medicine"},{"key":"10.1053\/bega.1999.0076_RF94","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2893.1997.00120.x","article-title":"The spectrum of extrahepatic manifestations in hepatitis C virus infection","volume":"4","author":"Hadziyannis","year":"1997","journal-title":"Journal of Viral Hepatitis"},{"key":"10.1053\/bega.1999.0076_RF95","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1468-3083.1998.tb00922.x","article-title":"Skin diseases associated with hepatitis C virus infection","volume":"10","author":"Hadziyannis","year":"1998","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"10.1053\/bega.1999.0076_RF96","first-page":"367","article-title":"Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C","volume":"7","author":"Barreca","year":"1995","journal-title":"European Journal of Gastroenterology & Hepatology"},{"key":"10.1053\/bega.1999.0076_RF97","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF02347624","article-title":"Development of Sj\u00f8gren's syndrome during treatment with recombinant human interferon-alpha-2b for chronic hepatitis C","volume":"31","author":"Unoki","year":"1996","journal-title":"Journal of Gastroenterology"},{"key":"10.1053\/bega.1999.0076_RF98","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/hep.510260127","article-title":"Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy","volume":"26","author":"Deutsch","year":"1997","journal-title":"Hepatology"}],"container-title":["Best Practice &amp; Research Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691899900768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521691899900768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T05:29:22Z","timestamp":1621142962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521691899900768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S1521691899900768"],"URL":"https:\/\/doi.org\/10.1053\/bega.1999.0076","relation":{},"ISSN":["1521-6918"],"issn-type":[{"value":"1521-6918","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}